PTPRC and neoplasm: Consistently, in our HLA-A2 restricted TCR-pMHC system (Fig. 7g–n), CD45-overexpressing tumor cells were shown to cause CD45 aggregation in immune synapse to suppress the activation of TCR signaling of T cells.